Bio Logic Aqua Research brings dry eye mist to market
Bio Logic Aqua Research last week launched its Nature’s Tears EyeMist solution for dry eye.
Bio Logic Aqua Research’s dry eye solution consists of 100% pure tissue culture grade water. This water is pH-balanced and biocompatible with the water content of the natural tear film. This dry eye solution’s patented micron-size mist, applied with a personal, portable hand-held humidifier, instantly rehydrates the tear film while also moisturizing the skin of the eyelids and the skin around the eyes.
And the dry eye solution Nature’s Tears EyeMist is safe for infants suffering from dry eye disease and it does not cause eye make-up to “run.”
Many people suffering from dry eye disease use eye drops, most of them saline solutions, for relief, noted Sharon Kleyne, director research at Bio-Logic Aqua Research, which operates out of Grants Pass, Ore. “But dry eye disease is tougher than eye drops. Eye drops do not supplement or replenish moisture that has been lost to evaporation as a result of dry eye disease. Dry eye disease will continue until the eye’s moisture is replenished with sterile water. Without sterile water, dry eye disease symptoms just grow worse,” Kleyne said.
Dry eye disease afflicts 30 million in the U.S. The eye’s tear film is naturally 99% water, yet when it over-evaporates, dry eye symptoms occur. These symptoms include burning, itching, swelling, redness, headaches and blurred vision.
American Red Cross recognizes Tender for relief efforts
Tender, a leading manufacturer of insect repellents and bite treatments, has been formally recognized by the American Red Cross for its support of relief efforts following one of the most destructive hurricanes ever to strike Puerto Rico.
In September 2017, Tender contributed over 15,000 units of Repel Bite, a DEET-based insect repellent, and After Bite, a pharmacist-preferred insect sting and bite treatment, as part of Hurricane Maria relief efforts led by American Red Cross New Hampshire and Vermont Region. The Red Cross then distributed the supplies, valued at nearly $30,000, to affected residents, offering protection from expanded mosquito populations during the cleanup and reconstruction processes.
“Mosquitoes thrive in the wake of hurricanes because of the abundance of standing water, and we knew we had an opportunity to help,” Jason Cartwright, CEO of Tender, said. “We are humbled to receive such an acknowledgement from the Red Cross. Moreover, we’re grateful that Tender Corp.’s contribution made a positive impact on the lives of those affected by this devastating storm.”
In February, Maria Delvin, CEO of American Red Cross New Hampshire and Vermont, and Jessica Blais, American Red Cross regional philanthropy officer, visited Tender Corp.’s headquarters in Littleton, New Hampshire, to present a plaque in recognition of the company’s vital support during hurricane response efforts.
“The local partnership with Tender allowed us to quickly mobilize vital products to an area that was severely devastated by this storm—and for that we are grateful,” says Blais.
CRN calls on FDA for greater enforcement at the border
The Council for Responsible Nutrition on Tuesday commended a recent FDA announcement reporting an increase in scrutiny of potential unsafe, counterfeit or unapproved medicines from entering the country, but called on the agency to follow through with increased enforcement.
“Every year thousands of packages are found to contain FDA-regulated products and a surprising percentage of those products are illegal. These products come in all different shapes and forms – some with sophisticated packaging and others in nondescript plastic bags,” Scott Gottlieb, commissioner FDA, noted in a blog posted last week. “They include unapproved products; counterfeit or substandard drugs; and purported dietary supplements being sold for weight loss, sexual enhancement, bodybuilding or pain relief. Many products promoted as dietary supplements contain potentially dangerous undeclared drug ingredients.”
“We applaud FDA for increasing its efforts to prevent illegal drugs with hidden ingredients from entering the United States. The responsible industry has been adamant about the need for FDA to increase the effectiveness of its regulation of dietary supplements, and we have been fighting for more resources for the agency to achieve this,” Steve Mister, president and CEO CRN, said. “Shifting the paradigm for how the agency screens products at international mail facilities is a positive step, but increased intelligence is only valuable if it is used appropriately.”
Mister wants the increased scrutiny to result in recalls and import alerts so that business partners and recipients of these ingredients here in the U.S. can be on alert to discontinue their affiliations with potentially nefarious sources. “We also urge the agency to make public the identities of the perpetrators and to refer them for enforcement by the Department of Justice. Bad actors deserve public scrutiny and criminal prosecution, and FDA has the authority to take these actions,” Mister said.
Gottlieb reported that, using a new screening device, as many as 65% of packages screened tested positive for the presence of undeclared pharmaceutical ingredients, results that were later confirmed in an FDA laboratory. While the packages were not randomly selected, many were identified beforehand as suspicious packages, that’s still an alarming rate.
CRN also cautioned against taking FDA’s findings out of context and making generalizations about the dietary supplement industry as a whole. The percentage of samples that tested positive for the presence of undeclared pharmaceutical ingredients, while disturbing, is not generalizable to the mainstream dietary supplement market, Mister argued. “The agency was targeting high-risk packages at international mail facilities with additional surveillance; it specifically identified products it suspected of containing illegal ingredients, and unfortunately, in many of those packages, it found them. High-risk international mail packages are not a representative sample of the U.S. marketplace as a whole.”